P-gp upregulation may be blocked by natural curcuminoids, a novel class of chemoresistance-preventing agent.

@article{Xu2013PgpUM,
  title={P-gp upregulation may be blocked by natural curcuminoids, a novel class of chemoresistance-preventing agent.},
  author={Dong Xu and W. Tian and Hong Shen},
  journal={Molecular medicine reports},
  year={2013},
  volume={7 1},
  pages={
          115-21
        }
}
Once multidrug resistance (MDR) occurs in cancer cells, it is very difficult to reverse since overexpression of P-glycoprotein (P-gp) is accompanied by altered expression of numerous other activated target genes. Previously, we reported that curcumin pretreatment would be an ideal method to prevent acquired drug resistance induced by adriamycin, administered prior to the development of MDR. To further confirm the previous results, we examined the potency of 3 forms of curcuminoids present in… 
Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and Perspectives
TLDR
The effects ofCurcumin and several curcumin analogs on P-glycoprotein function and expression are summarized and compared, emphasizing the potential of these molecules for the possible development of safe and effective inhibitors of P-gp to overcome MDR in human cancer.
Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line.
TLDR
The data clearly suggest that DATS has significant anticancer effects on human osteosarcoma cells, and the potential mechanisms include reducing the multidrug resistance and inducing apoptosis.
Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines
TLDR
Novel evidence of the previously unknown therapeutic effects of curcumin, either alone or in combination with cisplatin on the inhibition of the CD166+/EpCAM+ subpopulation of NSCLC cell lines is provided.
P-Glycoprotein: A Critical Comparison of Models Depicting Mechanism of Drug Efflux and Role of Modulators
TLDR
It has been observed that contrary to the earlier reported models where transmembrane domain is the preferred binding site of ligands resulting in their efflux through ATP hydrolysis at nucleotide binding domain (NBD) site, the more hydrophilic NBD appears to be the appropriate binding site for majority of the hydrophobic third and fourth generation modulators thus inhibiting the binding and Hydrolysis of ATP resulting in inhibition of efflux.
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.
TLDR
A number of novel strategies used by small-molecule inhibitors to prevent the development of multidrug resistance hold great promise for prolonging the efficacy of chemotherapy treatment and improving the clinical outcomes of patients with cancers that are susceptible to MDR development.
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
TLDR
This review provides an overview of the recent research conducted to overcome the problems with the bioavailability of curcumin, and of the preclinical and clinical studies that have reported success in combinatorial strategies couplingCurcumin with other treatments.
Curcuma Contra Cancer? Curcumin and Hodgkin’s Lymphoma
TLDR
Curcumin can inhibit growth of HL cell lines and increases the sensitivity of these cells for cisplatin, with special focus on possible activities against HL cells.
Fonctionnalisation de biopolymères extraits de macroalgues pour encapsuler des principes actifs hydrophobes
Le diabete est caracterise par une hyperglycemie chronique mais egalement par un stress oxydant et une inflammation chronique conduisant a des complications cardiovasculaires telles que
...
1
2
...

References

SHOWING 1-10 OF 29 REFERENCES
Curcumin prevents induced drug resistance: A novel function?
TLDR
It is suggested that curcumin exhibits the novel ability to prevent the up-regulation of P-gp and its mRNA induced by ADM and the prevention capacity is also functionally associated with the elevated intracellular drug accumulation and parallel enhanced ADM cytotoxicity.
Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids
TLDR
It is indicated that bisdemethoxycurcumin is the most active of the curcuminoids present in turmeric for modulation of MDR-1 gene, which may be an attractive target for new chemosensitizing agents.
Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells
TLDR
The results suggest that curcumin is an inhibitor of MRP5 and may be useful in the reversal of multi-drug resistance in pancreatic cancer chemotherapy.
Cyclosporin A and PSC 833 prevent up-regulation of MDR1 expression by anthracyclines in a human multidrug-resistant cell line.
TLDR
Both PSC 833 and CyA appear to prevent the induction of MDR1 gene expression caused by the short-term exposure of CEM/A7R cells to EPI.
Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription
TLDR
Tetrandrine can prevent doxorubicin-induced mdr1 mRNA/P-gp expression and P-gp functions in a dose-dependent manner through a mechanism that may involve inhibition of dox orubic in-induced NF-κB mRNA expression and protein activity.
Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1)
TLDR
Results demonstrate that curcuminoids effectively inhibit MRP1-mediated transport and amongCurcumin I, a major constituent of cur cumin mixture, is the best modulator.
P-glycoprotein (MDR1) Expression in Leukemic Cells Is Regulated at Two Distinct Steps, mRNA Stabilization and Translational Initiation*
TLDR
The key regulatory steps in the development of multidrug resistance in K562 myelogenous leukemic cells are characterized and up-regulation of MDR1 levels was not due to transcriptional activation but was achieved at two distinct post-transcriptional steps, mRNA turnover and translational regulation.
Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
...
1
2
3
...